glp 1 and gip receptors Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Potential of a glucagon‐like peptide‐1

Side Effects: As a GLP-1 therapy, common side effects are typically gastrointestinal, including nausea, vomiting, and diarrhea.

But researchers arent done sharpening the edge

Indication expansion, such as approvals for additional metabolic and cardiovascular conditions, is broadening patient access and driving adoption

95% CI 0.310.50), MACEs (aHR 0.66

Adults with type 2 diabetes and cancer who used a GLP-1 had a lower risk for death and hospitalization compared with adults who used metformin, according to findings published in The Journal of Clinical Endocrinology &amp

Please forgive a slight measurement deviation due to manual measurement.